News

2022 Dec 30

Awards and Honors – December 30, 2022

Dr. Duncan Hau , assistant professor of clinical pediatrics, has been elected to the Association of Pediatric Program Directors ’ Global Health Learning Community Steering Committee. Committee members are global health... Read more

2022 Dec 28

Enzyme That Protects Against Viruses Could Fuel Cancer Evolution

An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine... Read more

2022 Dec 15

Potential Therapy for an Aggressive Type of Colon Cancer Identified in Preclinical Studies

An experimental therapy showed promise as treatment for an aggressively spreading type of colorectal cancer in preclinical models, according to a new study by Weill Cornell Medicine investigators. Mesenchymal colorectal... Read more

2022 Dec 07

Weill Cornell Medicine Receives Grant to Study Effects of Radiation on Immunity

Weill Cornell Medicine has been awarded a five-year, $8.1 million grant from the National Cancer Institute of the National Institutes of Health to investigate the effects of the immune response in irradiated rectal cancer... Read more

2022 Dec 01

To Trigger Crohn’s Disease, Pathogenic Bacteria Co-opt a Genetic Susceptibility

Changes in a single gene open the door for harmful gut bacteria to set off the inflammation that drives Crohn’s disease, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators. These... Read more

2022 Nov 30

Awards and Honors – November 30, 2022

Dr. Erika Abramson , professor of pediatrics, has been named a member of the American Pediatric Society. Members of the society are recognized as child health leaders who work together to shape the future of academic... Read more

FOXO1 and p300 interaction demonstrated by red fluorescence.

2022 Nov 22

Discovery Suggests New Way to Target Mantle Cell Lymphoma

A form of blood cancer known as mantle cell lymphoma is critically dependent on a protein that coordinates gene expression, such that blocking its activity with an experimental drug dramatically slows the growth of this... Read more

2022 Nov 11

NIH Grant Funds Cancer Prevention Vaccine Research

A multidisciplinary team of Weill Cornell Medicine researchers has received a five-year $5.7 million grant from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing... Read more

2022 Oct 28

Awards and Honors – October 28, 2022

Five physicians in the Department of Radiology have been named fellows of the American College of Radiology. The recipients have been awarded based on their history of service to the college, organized radiology, teaching... Read more

2022 Oct 25

Dr. Holly Prigerson Receives NCI Award to Improve End-Stage Cancer Care

Dr. Holly G. Prigerson , the Irving Sherwood Wright Professor in Geriatrics and co-director of the Center for Research on End-of-Life Care at Weill Cornell Medicine, has been awarded a National Cancer Institute Outstanding... Read more

2022 Oct 19

Corrupt Endothelial Cells Protect Blood Cancer Cells from Chemotherapy

Endothelial cells—the cells that line blood vessels—grown alongside leukemia cells become corrupted and rescue the cancer cells from many chemotherapy drugs, a study by Weill Cornell Medicine investigators found. A growing... Read more

2022 Sep 29

Fungal Association with Tumors May Predict Worse Outcomes

The presence of some fungal species in tumors predicts—and may even help drive—worse cancer outcomes, according to a study from Weill Cornell Medicine and Duke University researchers. The study , which appears Sept. 29 in... Read more

diagram of loss of nuclear soluble adenylyl cyclase in melanoma cells

2022 Sep 27

Novel Technique Reveals Surprising New Way to Suppress Tumor Cells

By analyzing key enzymes in a new way, an international team led by researchers at Weill Cornell Medicine has discovered how a well-known signaling molecule can either stimulate or suppress tumor growth depending on where it... Read more

2022 Sep 26

A New Tool for Discovering Cancer-Driving Structural Variations

An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers. In the study , published Sept. 26 in Nature... Read more

2022 Sep 22

Study Illuminates Precancerous "Clonal Outgrowth" in Blood Cells

A common, spontaneous mutation in blood stem cells, which has been linked to higher risks of blood cancer and cardiovascular disease, may promote these diseases by altering the stem cells’ programming of gene activity and... Read more

2022 Sep 19

Biological Links Identified Between an Aggressive Breast Cancer Type and African Ancestry

Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer (TNBC). Their... Read more

2022 Sep 14

New MCC Deputy Director Dr. Taha Merghoub Discusses His Passion for Cancer Research and Shares What It Means to “Push Boundaries” as a Scientist

There is no single event that inspired Dr. Taha Merghoub’s journey from his childhood in the Sahara Desert to his recent appointment as deputy director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine... Read more

2022 Sep 13

USF Health, Weill Cornell Medicine Earn Inaugural Funding in NIH’s Newly Launched Bridge2AI Initiative, will Create Artificial Intelligence Platform for Using Voice to Diagnose Disease

Tampa FL (Sept. 13, 2022) – Artificial intelligence may soon help doctors diagnose and treat diseases, including cancer and depression, based on the sound of a patient’s voice, as 12 leading research institutions launch a... Read more

2022 Sep 01

Department of Defense Awards Weill Cornell Medicine New Grant for Kidney Cancer Research

Weill Cornell Medicine has been awarded a $1 million, three-year grant from the Department of Defense’s Kidney Cancer Research Program to fund research on the role of the protein ATF4 in clear cell renal cell carcinoma (... Read more

progressively zoomed in image of thymic cancer

2022 Aug 29

New Preclinical Model Could Accelerate Research on Thymic Cancer

A new preclinical model for thymic cancer developed by Weill Cornell Medicine investigators has revealed insights into how a common mutation found in thymic epithelial tumors sparks their formation. The model may help speed... Read more